Results 141 to 150 of about 83,111 (263)

[Primary biliary cirrhosis: liver transplantation].

open access: yesNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999
M, Hirata, Y, Harihara, M, Makuuchi
openaire   +1 more source

IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury

open access: yesLiver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background and Aims Immune‐mediated bile duct injury is the primary histological feature of autoimmune cholestatic liver diseases. Macrophages, the most abundant immune cell population in the liver, have been postulated to play a critical role in biliary repair. However, it is unclear whether activated macrophages interact with injured biliary
Xing Zhou   +12 more
wiley   +1 more source

Empagliflozin-Induced Liver Injury. [PDF]

open access: yesEur J Case Rep Intern Med
Gonçalves HD   +6 more
europepmc   +1 more source

Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre Study

open access: yesLiver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background & Aims Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) go along with reduced health‐related quality of life (HRQOL). Variant syndromes, that is, conditions with features of both PBC/PSC and AIH, are associated with higher clinical complexity and worse prognosis. Studies on HRQOL
Natalie Uhlenbusch   +34 more
wiley   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy